Article
Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk
28 Feb 2021
Abstract excerpt
Recent advances in proteomic technologies have made high-throughput profiling of low-abundance proteins in large epidemiological cohorts increasingly feasible. We investigated whether aptamer-based proteomic profiling could identify biomarkers associated with future development of type 2 diabetes (T2DM) beyond known risk factors. We identified dozens of markers with highly significant associations with future...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
